Page results
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.
-
Prime Minister Boris Johnson visited the vaccination centre at the Islington Business Design Centre yesterday.
-
To enable us to provide a quick response when you need it most, we have developed these Frequently Asked Questions (FAQs). We kindly ask you to read through these before contacting our team as you may find the answer to your question here.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
A healthcare project aimed at homeless people and delivered by UCLH has been specially commended in this year’s London Homelessness Awards.
-
UCLH continues to achieve excellent results in the National Inpatient Survey. In 2021 patients rated their overall care as 8.5 out of 10 which is the top score in London and the second best in the Shelford Group.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
File results
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology
-
FOI/2022/0304 - Histopathology labs that run immunohistochemistry diagnostic testing
-
FOI/2022/0305 - Ethnic minority categories used for Gypsy, Roma, Traveller groups
-
FOI/2022/0306 - Policy and associates procedure using robotics
-
FOI/2022/0309 - In-patient deaths
-
FOI/2022/0314 - Use of herbicide containing glyphosate on hospital grounds
-
FOI/2022/0315 - Role of patient safety specialists within the Trust
-
FOI/2022/0317 - Inpatient mental health facilities
-
FOI/2022/0318 - HIMMS Electronic Medical Record Adoption Model (EMRAM) level achieved at Trust
-
FOI/2022/0325 - Number of patients on the public RTT pathway